跳至主要内容
临床试验/NCT04000789
NCT04000789Unknown不适用

The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)

Dr Cipto Mangunkusumo General Hospital0 个研究点目标入组 96 人开始时间: 2019年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
96
主要终点
Ocular Surface Disease Index (OSDI) questionnaire

研究概览

简要总结

Commonly know that one of the complications caused by Diabetes Mellitus (DM) is microangiopathy. Microangiopathy in the long term may lead to neuropathy of the corneal nerves. Neuropathy of the cornea will lead to dry eyes in DM patient. One of the artificial tears used in treating dry eyes is sodium hyaluronate. But until recently no research had been done in examining the effect of giving combination of sodium hyaluronate, vitamin A and vitamin E in dry eyes. The antioxidant, and capability of vitamin A and E in promoting cell proliferation may alleviate the symptoms of dry eyes. In this paper we used Ocular Surface Disease Index (OSDI), Tear Break Up time, Schirmer I test and impression cytology to assess baseline and 28 days post therapy in patient with Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)

详细描述

The study is double blind randomized clinical trial, comparing the usage of combination of sodium hyaluronate 0.15%, vitamin A and vitamin E eye drops compared to sodium hyaluronate 0.1% eye drop only in patient with NPDR or PDR with decreased corneal sensitivity. The examination consisted of OSDI questionnaire, tear film break up time, Schirmer I, and goblet cell density, examined at baseline and 4 weeks (day 28) after the initial eye drops is given. For sample size calculation, estimated 96 patients are required to give statistical effect, this number already calculating the possibility of 20% drop out rate. Every eligible patient is then randomized with block randomization into each allocated arm. Statistical analysis used for this study is unpaired T test if the data distribution is normal, if not Mann-Whitney test will be used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DM patients with NPDR or PDR
  • Corneal sensitivity less than 45 mm with Cochet Bonnet esthesiometer

排除标准

  • Patient with anterior chamber inflammation
  • Patient with history of ocular surgery (ex. Repair of corneal rupture, cataract surgery, Lasik)
  • Patient with history of cerebrovascular event that may affect cognitive function
  • Patient had event of disease which may impact corneal sensitivity (ex. Viral keratitis, ophthalmic Herpes Zoster)
  • Patient with corneal cicatrix
  • Patient on anti-allergic medication
  • Pregnant or lactating woman

研究组 & 干预措施

NPDR

Experimental

干预措施: Sodium Hyaluronate, Vitamin A, Vitamin E (Drug)

NPDR Comparator

Active Comparator

干预措施: Sodium Hyaluronate, Vitamin A, Vitamin E (Drug)

PDR

Experimental

干预措施: Sodium Hyaluronate, Vitamin A, Vitamin E (Drug)

PDR Comparator

Active Comparator

干预措施: Sodium Hyaluronate, Vitamin A, Vitamin E (Drug)

结局指标

主要结局

Ocular Surface Disease Index (OSDI) questionnaire

时间窗: 4 weeks

A questionnaire to measure subjective symptoms of dry eyes. Possible score of 0 (no dry eye) to 100 (severe dry eye). Measured at baseline, day 14 and day 28.

Tear Film Breakup Time

时间窗: 4 weeks

Measurement in seconds of tear film stability. The shorter the fluorescein tear break up time, the lower the tear film stability. Measured at baseline and day 28.

Schirmer I Test

时间窗: 4 weeks

Measurement of tear production. The amount of tears are measured in total millimeters after 5 minutes has elapsed. Measured at baseline and day 28.

Conjunctival Goblet Cell Density

时间窗: 4 weeks

Measurement of conjunctival goblet cell count per mm2. Measured at baseline and day 28.

次要结局

未报告次要终点

研究者

发起方
Dr Cipto Mangunkusumo General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Made Susiyanti

dr.

Dr Cipto Mangunkusumo General Hospital

相似试验